Study Results from National Institute of Allergy and Infectious Diseases (NIAID) Update Understanding of Aedes aegypti (Antibodies to Aedes aegypti D7L salivary proteins as a new serological tool to estimate human exposure to Aedes mosquitoes).

MLA

“Study Results from National Institute of Allergy and Infectious Diseases (NIAID) Update Understanding of Aedes Aegypti (Antibodies to Aedes Aegypti D7L Salivary Proteins as a New Serological Tool to Estimate Human Exposure to Aedes Mosquitoes).” Vaccine Weekly, May 2024, p. 327. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=177153151&authtype=sso&custid=ns315887.

APA

Study Results from National Institute of Allergy and Infectious Diseases (NIAID) Update Understanding of Aedes aegypti (Antibodies to Aedes aegypti D7L salivary proteins as a new serological tool to estimate human exposure to Aedes mosquitoes). (2024). Vaccine Weekly, 327.

Chicago

“Study Results from National Institute of Allergy and Infectious Diseases (NIAID) Update Understanding of Aedes Aegypti (Antibodies to Aedes Aegypti D7L Salivary Proteins as a New Serological Tool to Estimate Human Exposure to Aedes Mosquitoes).” 2024. Vaccine Weekly, May, 327. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=177153151&authtype=sso&custid=ns315887.